Amy Schacterle Acumen Pharmaceuticals, Inc. (ABOS) insider trading activity

ABOS Quotes by TradingView

Amy Schacterle is Chief Regulatory Officer of Acumen Pharmaceuticals, Inc.. Currently has a direct ownership of 7,703 shares of ABOS, which is worth approximately $13,711. The most recent transaction as insider was on Jan 07, 2026, when has been sold 1,097 shares (Common Stock) at a price of $1.98 per share, resulting in proceeds of $2,172. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.7K
12.47% 3M change
12.47% 12M change
Total Value Held $13,711

Amy Schacterle Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 07 2026
SELL
Open market or private sale
$2,172 $1.98 p/Share
1,097 Reduced 12.47%
7,703 Common Stock
Jan 06 2025
BUY
Grant, award, or other acquisition
-
8,800 Added 50.0%
8,800 Common Stock
AS

Amy Schacterle

Chief Regulatory Officer
Newton, MA

Track Institutional and Insider Activities on ABOS

Follow Acumen Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABOS shares.

Notify only if

Insider Trading

Get notified when an Acumen Pharmaceuticals, Inc. insider buys or sells ABOS shares.

Notify only if

News

Receive news related to Acumen Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ABOS